148 related articles for article (PubMed ID: 32215865)
41. 2-[Fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience.
Komori T; Narabayashi I; Matsumura K; Matsuki M; Akagi H; Ogura Y; Aga F; Adachi I
Ann Nucl Med; 2007 Jun; 21(4):209-15. PubMed ID: 17581719
[TBL] [Abstract][Full Text] [Related]
42. Advanced magnetic resonance imaging (MRI) of soft tissue tumors: techniques and applications.
Bruno F; Arrigoni F; Mariani S; Splendiani A; Di Cesare E; Masciocchi C; Barile A
Radiol Med; 2019 Apr; 124(4):243-252. PubMed ID: 30949892
[TBL] [Abstract][Full Text] [Related]
43. PET and SPECT.
Haberkorn U
Handb Exp Pharmacol; 2008; (185 Pt 2):13-35. PubMed ID: 18626597
[TBL] [Abstract][Full Text] [Related]
44. In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals.
Huh YM; Jun YW; Song HT; Kim S; Choi JS; Lee JH; Yoon S; Kim KS; Shin JS; Suh JS; Cheon J
J Am Chem Soc; 2005 Sep; 127(35):12387-91. PubMed ID: 16131220
[TBL] [Abstract][Full Text] [Related]
45. 99mTc-Labeled Iron Oxide Nanoparticles for Dual-Contrast (T1/T2) Magnetic Resonance and Dual-Modality Imaging of Tumor Angiogenesis.
Xue S; Zhang C; Yang Y; Zhang L; Cheng D; Zhang J; Shi H; Zhang Y
J Biomed Nanotechnol; 2015 Jun; 11(6):1027-37. PubMed ID: 26353592
[TBL] [Abstract][Full Text] [Related]
46. From molecular imaging in preclinical/clinical oncology to theranostic applications in targeted tumor therapy.
Alberti C
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1925-33. PubMed ID: 23242718
[TBL] [Abstract][Full Text] [Related]
47. Molecular and functional imaging of breast cancer.
Tafreshi NK; Kumar V; Morse DL; Gatenby RA
Cancer Control; 2010 Jul; 17(3):143-55. PubMed ID: 20664511
[TBL] [Abstract][Full Text] [Related]
48. Prediction and Early Evaluation of Anticancer Therapy Response: From Imaging of Drug Efflux Pumps to Targeted Therapy Response.
Meng Q; Li Z; Li S
Curr Med Chem; 2016; 23(41):4625-4638. PubMed ID: 27804872
[TBL] [Abstract][Full Text] [Related]
49. Recent Advances in Magnetic Nanoparticle-based Molecular Probes for Hepatocellular Carcinoma Diagnosis and Therapy.
Zhang Q; Wang S; Qiao R; Whittaker MR; Quinn JF; Davis TP; Li H
Curr Pharm Des; 2018; 24(21):2432-2437. PubMed ID: 29788872
[TBL] [Abstract][Full Text] [Related]
50. Modification of MR molecular imaging probes with cysteine-terminated peptides and their potential for in vivo tumour detection.
Xu F; Lei D; Du X; Zhang C; Xie X; Yin D
Contrast Media Mol Imaging; 2011; 6(1):46-54. PubMed ID: 20865697
[TBL] [Abstract][Full Text] [Related]
51. [Prediction of Cancer Treatment Response by Physiologic and Metabolic Imaging].
Matsumoto S
Yakugaku Zasshi; 2016; 136(8):1101-5. PubMed ID: 27477724
[TBL] [Abstract][Full Text] [Related]
52. Imaging of thoracic cavity tumors.
Hayes SA; Plodkowski AJ; Ginsberg MS
Surg Oncol Clin N Am; 2014 Oct; 23(4):709-33. PubMed ID: 25246047
[TBL] [Abstract][Full Text] [Related]
53. MR/PET: a new challenge in hybrid imaging.
Werner MK; Schmidt H; Schwenzer NF
AJR Am J Roentgenol; 2012 Aug; 199(2):272-7. PubMed ID: 22826387
[TBL] [Abstract][Full Text] [Related]
54. Mathematical Models of Contrast Transport Kinetics for Cancer Diagnostic Imaging: A Review.
Turco S; Wijkstra H; Mischi M
IEEE Rev Biomed Eng; 2016; 9():121-47. PubMed ID: 27337725
[TBL] [Abstract][Full Text] [Related]
55. The role of various modalities in breast imaging.
Prasad SN; Houserkova D
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2007 Dec; 151(2):209-18. PubMed ID: 18345253
[TBL] [Abstract][Full Text] [Related]
56. Oral Administration and Detection of a Near-Infrared Molecular Imaging Agent in an Orthotopic Mouse Model for Breast Cancer Screening.
Bhatnagar S; Verma KD; Hu Y; Khera E; Priluck A; Smith DE; Thurber GM
Mol Pharm; 2018 May; 15(5):1746-1754. PubMed ID: 29696981
[TBL] [Abstract][Full Text] [Related]
57. Development and evaluation of a dual-modality (MRI/SPECT) molecular imaging bioprobe.
Misri R; Meier D; Yung AC; Kozlowski P; Häfeli UO
Nanomedicine; 2012 Aug; 8(6):1007-16. PubMed ID: 22100757
[TBL] [Abstract][Full Text] [Related]
58. Molecular Imaging of Breast Cancer: Role of RGD Peptides.
Chakravarty R; Chakraborty S; Dash A
Mini Rev Med Chem; 2015; 15(13):1073-94. PubMed ID: 26349490
[TBL] [Abstract][Full Text] [Related]
59. Current imaging paradigms in radiation oncology.
Apisarnthanarax S; Chao KS
Radiat Res; 2005 Jan; 163(1):1-25. PubMed ID: 15606303
[TBL] [Abstract][Full Text] [Related]
60. Noninvasive cell tracking.
Kiessling F
Handb Exp Pharmacol; 2008; (185 Pt 2):305-21. PubMed ID: 18626608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
